AAAAAA

   
Results: 1-17 |
Results: 17

Authors: HEDLEY LR JACOBSON LO SECCHI RL KHABBAZ M GOGAS KR HUNTER JC WHITING RL
Citation: Lr. Hedley et al., EFFECTS OF ENDOMORPHIN-1 AND ENDOMORPHIN-2 ON TAIL-FLICK LATENCY AND RESPIRATORY DEPRESSION IN RATS, The FASEB journal, 12(4), 1998, pp. 916-916

Authors: STANLEY WC LEE KH JOHNSON LG WHITING RL EGLEN RM HEGDE SS
Citation: Wc. Stanley et al., CARDIOVASCULAR EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL DOPAMINE-BETA-HYDROXYLASE INHIBITOR, Journal of cardiovascular pharmacology, 31(6), 1998, pp. 963-970

Authors: STANLEY WC LI B BONHAUS DW JOHNSON LG LEE K PORTER S WALKER K MARTINEZ G EGLEN RM WHITING RL HEGDE SS
Citation: Wc. Stanley et al., CATECHOLAMINE MODULATORY EFFECTS OF NEPICASTAT (RS-25560-197), A NOVEL, POTENT AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXYLASE, British Journal of Pharmacology, 121(8), 1997, pp. 1803-1809

Authors: WHITING RL STANLEY WC BONHAUS D JOHNSON LG LEE K PORTER S WALKER K EGLEN RM HEGDE SS
Citation: Rl. Whiting et al., PHARMACOLOGY OF RS-25560-197, A NOVEL AND SELECTIVE INHIBITOR OF DOPAMINE-BETA-HYDROXILASE, British Journal of Pharmacology, 120, 1997, pp. 170-170

Authors: TERRY AV BUCCAFUSCO JJ PRENDERGAST MA JACKSON WJ FONTANA DL WONG EHF WHITING RL EGLEN RM
Citation: Av. Terry et al., THE 5-HT3 RECEPTOR ANTAGONIST, RS-56812, ENHANCES DELAYED MATCHING PERFORMANCE IN MONKEYS, NeuroReport, 8(1), 1996, pp. 49-54

Authors: HEGDE SS STANLEY WC LEE K PORTER S WALKER K MARTINEZ G EGLEN RM WHITING RL
Citation: Ss. Hegde et al., CATECHOLAMINE MODULATORY AND CARDIOVASCULAR EFFECTS OF RS-25560-197, A NOVEL AND POTENT INHIBITOR OF DOPAMINE-BETA-HYDROXYLASE, Circulation, 94(8), 1996, pp. 2362-2362

Authors: HEGDE SS STANLEY WC LEE K WALKER K MARTINEZ G EGLEN RM WHITING RL
Citation: Ss. Hegde et al., SYNERGISTIC HEMODYNAMIC-EFFECTS OF A DOPAMINE-BETA-HYDROXYLASE INHIBITOR (RS-25560-197) AND ACE-INHIBITOR (ENALAPRIL) IN SPONTANEOUSLY HYPERTENSIVE RATS, Circulation, 94(8), 1996, pp. 2780-2780

Authors: FISHER LE ROSENKRANZ RP CLARK RD MUCHOWSKI JM MCCLELLAND DL MICHEL A CAROON JM GALEAZZI E EGLEN R WHITING RL
Citation: Le. Fisher et al., 6-BIS-[2-(3,4-DIHYDROXYBENZYL)PYRROLIDINYL]HEXANE, A POTENT, SELECTIVE, ORALLY-ACTIVE DOPAMINE ANALOG WITH HYPOTENSIVE AND DIURETIC ACTIVITY, Bioorganic & medicinal chemistry letters, 5(20), 1995, pp. 2371-2376

Authors: SHARIF NA NUNES JL ROSENKRANZ RP WHITING RL EGLEN RM
Citation: Na. Sharif et al., QUANTITATIVE AUTORADIOGRAPHY DEMONSTRATES SELECTIVE MODULATION OF RAT-BRAIN REGIONAL DOPAMINE (D-1 AND D-2) RECEPTOR SUBTYPES AFTER CHRONICMANIPULATION OF DIETARY SALT, Neurochemical research, 20(2), 1995, pp. 121-128

Authors: SHARIF NA TO ZP WONG KH DELMENDO RE WHITING RL EGLEN RM
Citation: Na. Sharif et al., M(3) MUSCARINIC RECEPTORS ON MURINE HSDM1C1 CELLS - FURTHER FUNCTIONAL, REGULATORY, AND RECEPTOR-BINDING STUDIES, Neurochemical research, 20(1), 1995, pp. 61-68

Authors: SHARIF NA NUNES JL LAKE KD MCCLELLAND DL CORKINS SF LAKATOS I ROSENKRANZ RP WHITING RL EGLEN RM
Citation: Na. Sharif et al., CHRONIC MANIPULATION OF DIETARY SALT MODULATES RENAL PHYSIOLOGY AND KIDNEY DOPAMINE-RECEPTOR SUBTYPES - FUNCTIONAL AND AUTORADIOGRAPHIC STUDIES, General pharmacology, 26(4), 1995, pp. 727-735

Authors: WONG EHF CLARK R LEUNG E LOURY D BONHAUS DW JAKEMAN L PARNES H WHITING RL EGLEN RM
Citation: Ehf. Wong et al., THE INTERACTION OF RS-25259-197, A POTENT AND SELECTIVE ANTAGONIST, WITH 5-HT3 RECEPTORS, IN-VITRO, British Journal of Pharmacology, 114(4), 1995, pp. 851-859

Authors: EGLEN RM LEE CH SMITH WL JOHNSON LG CLARK R WHITING RL HEGDE SS
Citation: Rm. Eglen et al., PHARMACOLOGICAL CHARACTERIZATION OF RS-25259-197, A NOVEL AND SELECTIVE 5-HT3 RECEPTOR ANTAGONIST, IN-VIVO, British Journal of Pharmacology, 114(4), 1995, pp. 860-866

Authors: EGLEN RM BONHAUS DW CLARK RD JOHNSON LG LEE CH LEUNG E SMITH WL WONG EHF WHITING RL
Citation: Rm. Eglen et al., (R)-RS-56532 AND (S)-RS-56532 - MIXED 5-HT3 AND 5-HT4 RECEPTOR LIGANDS WITH WITH OPPOSING ENANTIOMERIC SELECTIVITY, Neuropharmacology, 33(3-4), 1994, pp. 515-526

Authors: SHARIF NA WHITING RL
Citation: Na. Sharif et Rl. Whiting, THE NEUROPEPTIDE BRADYKININ STIMULATES PHOSPHOINOSITIDE TURNOVER IN HSDM1C1 CELLS - B2-ANTAGONIST-SENSITIVE RESPONSES AND RECEPTOR-BINDING STUDIES, Neurochemical research, 18(12), 1993, pp. 1313-1320

Authors: EGLEN RM LEE CH SMITH WL JOHNSON LG WHITING RL HEGDE SS
Citation: Rm. Eglen et al., RS-42358-197, A NOVEL AND POTENT 5-HT3 RECEPTOR ANTAGONIST, IN-VITRO AND IN-VIVO, The Journal of pharmacology and experimental therapeutics, 266(2), 1993, pp. 535-543

Authors: LEUNG E ALVAREZ R BONHAUS DW CLARK RD JOHNSON LG LEE CH SMITH WL WONG EHF WHITING RL EGLEN RM
Citation: E. Leung et al., (R)56532 AND (S)56532 - MIXED 5-HT(3) AND 5-HT(4) RECEPTOR LIGANDS WITH OPPOSING ENANTIOMERIC SELECTIVITY, British Journal of Pharmacology, 110, 1993, pp. 160000134-160000134
Risultati: 1-17 |